2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow Microphthalmia, Isolated, with Coloboma 5: new trials by email Literature Review of Microphthalmia, Isolated, with Coloboma 5 trials Research Report on Microphthalmia, Isolated, with Coloboma 5
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery CX 4945 - Medulloblastoma, Childhood, Medulloblastoma Recurrent | Phase 1 / Phase 2 | Terminated | Pediatric Brain Tumor Consortium | 21 | 2019-07-25 | 2026-10-19 |
| Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway vismodegib, Temozolomide - Histologically Confirmed Medulloblastoma, Activation of the Sonic Hedgehog (SHH) Pathway | Phase 1 / Phase 2 | Terminated | Centre Leon Berard | 24 | 2012-06-01 | 2019-05-21 |
Medulloblastoma (2)
Glioma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Neuroectodermal Tumors (2) · Neuroectodermal Tumors, Primitive (2)
HhAntag691 (1) · Temozolomide (1) · silmitasertib (1)
Centre Leon Berard (1) · Pediatric Brain Tumor Consortium (1)
France (1) · Italy (1) · Switzerland (1) · United Kingdom (1) · United States (1)
UM1CA081457 (1)